Shares of Enhabit, Inc. (NYSE:EHAB – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $12.10.
A number of analysts have weighed in on EHAB shares. Citigroup reissued a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Oppenheimer upgraded shares of Enhabit from a “market perform” rating to an “outperform” rating and set a $14.00 target price for the company in a research note on Thursday, January 22nd. UBS Group raised Enhabit from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $8.50 to $12.00 in a research report on Thursday, January 8th. TD Cowen raised Enhabit to a “buy” rating in a report on Tuesday, January 13th. Finally, Truist Financial set a $10.50 price objective on Enhabit and gave the stock a “hold” rating in a report on Wednesday, January 7th.
Get Our Latest Analysis on EHAB
Institutional Investors Weigh In On Enhabit
Enhabit Stock Down 0.6%
Shares of EHAB stock opened at $11.16 on Friday. Enhabit has a 12 month low of $6.47 and a 12 month high of $11.45. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75. The firm has a market cap of $564.55 million, a PE ratio of -44.62 and a beta of 1.66. The stock has a 50 day moving average of $10.16 and a 200-day moving average of $8.78.
Enhabit Company Profile
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Stories
- Five stocks we like better than Enhabit
- ALERT: Drop these 5 stocks before January 2026!
- Buy This Stock Now
- Trump Planning to Use Public Law 63-43: Prepare Now
- Trump & Musk’s Secret Bet on Silver — Exposed
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
